Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Fernández-Bello

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 30, 2017
The pharmacokinetics and pharmacodynamics of single-dose and multiple-dose recombinant activated factor VII in patients with haemophilia A or BI Fernández-Bello, C Stenmo, N Butta, et al.
Thrombosis and Haemostasis|February 15, 2013
Platelet apoptosis and agonist-mediated activation in myelodysplastic syndromesM Martín, R de Paz, V Jiménez-Yuste, et al.
Thrombosis and Haemostasis|February 7, 2014
Effects of thrombopoietin receptor agonists on procoagulant state in patients with immune thrombocytopeniaM T Alvarez Román, I Fernández Bello, E G Arias-Salgado, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 24, 2004
Surgery in haemophilic patients with inhibitor: 20 years of experienceM Quintana-Molina, F Martínez-Bahamonde, E González-García, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 12, 2018
Evaluation of EC50 of factor VIII as predictor of prophylaxis efficacy in patients with severe haemophilia AI Fernández-Bello, F Rode, M T Álvarez-Román, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 30, 2017
The pharmacokinetics and pharmacodynamics of single-dose and multiple-dose recombinant activated factor VII in patients with haemophilia A or BI Fernández-Bello, C Stenmo, N Butta, et al.
Thrombosis and Haemostasis|February 15, 2013
Platelet apoptosis and agonist-mediated activation in myelodysplastic syndromesM Martín, R de Paz, V Jiménez-Yuste, et al.
Thrombosis and Haemostasis|February 7, 2014
Effects of thrombopoietin receptor agonists on procoagulant state in patients with immune thrombocytopeniaM T Alvarez Román, I Fernández Bello, E G Arias-Salgado, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 24, 2004
Surgery in haemophilic patients with inhibitor: 20 years of experienceM Quintana-Molina, F Martínez-Bahamonde, E González-García, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 12, 2018
Evaluation of EC50 of factor VIII as predictor of prophylaxis efficacy in patients with severe haemophilia AI Fernández-Bello, F Rode, M T Álvarez-Román, et al.
Pageof 1